{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:00:01Z","timestamp":1793012401788,"version":"4.5.0"},"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["JP20K08400"],"award-info":[{"award-number":["JP20K08400"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>We recently reported that multilineage-differentiating stress enduring (Muse) cells intravenously administered after acute myocardial infarction (AMI), selectively engrafted to the infarct area, spontaneously differentiated into cardiomyocytes and vessels, reduced the infarct size, improved the left ventricular (LV) function and remodeling in rabbits. We aimed to clarify the efficiency of Muse cells in a larger animal AMI model of mini-pigs using a semi-clinical grade human Muse cell product.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Method and result<\/jats:title>\n<jats:p>Mini-pigs underwent 30 min of coronary artery occlusion followed by 2 weeks of reperfusion. Semi-clinical grade human Muse cell product (1x10<jats:sup>7<\/jats:sup>, Muse group, n = 5) or saline (Vehicle group, n = 7) were intravenously administered at 24 h after reperfusion. The infarct size, LV function and remodeling were evaluated by echocardiography. Arrhythmias were evaluated by an implantable loop recorder. The infarct size was significantly smaller in the Muse group (10.5\u00b13.3%) than in the Vehicle group (21.0\u00b12.0%). Both the LV ejection fraction and fractional shortening were significantly greater in the Muse group than in the Vehicle group. The LV end-systolic and end-diastolic dimensions were significantly smaller in the Muse group than in the Vehicle group. Human Muse cells homed into the infarct border area and expressed cardiac troponin I and vascular endothelial CD31. No arrhythmias and no blood test abnormality were observed.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Muse cell product might be promising for AMI therapy based on the efficiency and safety in a mini-pig AMI.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0265347","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T21:40:58Z","timestamp":1648158058000},"page":"e0265347","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Human Muse cells reduce myocardial infarct size and improve cardiac function without causing arrythmias in a swine model of acute myocardial infarction"],"prefix":"10.1371","volume":"17","author":[{"given":"Yoshihisa","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Minatoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanae","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Wakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Okura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Dezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8159-9697","authenticated-orcid":true,"given":"Shinya","family":"Minatoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"pone.0265347.ref001","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cardiores.2005.11.001","article-title":"Bone marrow-derived myocyte-like cells and regulation of repair-related cytokines after bone marrow cell transplantation","volume":"69","author":"Y Misao","year":"2006","journal-title":"Cardiovasc Res"},{"key":"pone.0265347.ref002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2005.06.008","article-title":"A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease","author":"S Yokoyama","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"pone.0265347.ref003","doi-asserted-by":"crossref","first-page":"H2670","DOI":"10.1152\/ajpheart.01071.2003","article-title":"Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis","volume":"287","author":"N Nagaya","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"pone.0265347.ref004","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0003-4975(02)03517-8","article-title":"Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects","volume":"73","author":"JG Shake","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"pone.0265347.ref005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.trsl.2009.06.009","article-title":"Stem cell therapy in acute myocardial infarction: a review of clinical trials","volume":"155","author":"JC George","year":"2010","journal-title":"Transl Res"},{"issue":"9","key":"pone.0265347.ref006","first-page":"CD006536","article-title":"Stem cell treatment for acute myocardial infarction","volume":"30","author":"SA Fisher","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"19","key":"pone.0265347.ref007","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1073\/pnas.0911647107","article-title":"Unique multipotent cells in adult human mesenchymal cell populations","volume":"107","author":"Y Kuroda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"pone.0265347.ref008","doi-asserted-by":"crossref","first-page":"9875","DOI":"10.1073\/pnas.1100816108","article-title":"Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts","volume":"108","author":"S Wakao","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"pone.0265347.ref009","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nprot.2013.076","article-title":"Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells","volume":"8","author":"Y Kuroda","year":"2013","journal-title":"Nat Protoc"},{"issue":"7","key":"pone.0265347.ref010","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1089\/scd.2013.0473","article-title":"Human adipose tissue possesses a unique population of pluripotent stem cells with nontumorigenic and low telomerase activities: potential implications in regenerative medicine","volume":"23","author":"F Ogura","year":"2014","journal-title":"Stem Cells Dev"},{"issue":"6","key":"pone.0265347.ref011","doi-asserted-by":"crossref","first-page":"e64752","DOI":"10.1371\/journal.pone.0064752","article-title":"Awakened by cellular stress: isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue","volume":"8","author":"S Heneidi","year":"2013","journal-title":"PLoS One"},{"key":"pone.0265347.ref012","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1253\/circj.CJ-17-0552","article-title":"Mobilized Muse cells after acute myocardial infarction predict cardiac function and remodeling in the chronic phase","volume":"82","author":"T Tanaka","year":"2018","journal-title":"Circ J"},{"key":"pone.0265347.ref013","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/CIRCRESAHA.117.311648","article-title":"S1P-S1PR2 axis mediates homing of Muse cells into damaged heart for long-lasting tissue repair and functional recovery after acute myocardial infarction","volume":"122","author":"Y Yamada","year":"2018","journal-title":"Circ Res"},{"key":"pone.0265347.ref014","doi-asserted-by":"crossref","first-page":"H1124","DOI":"10.1152\/ajpheart.00707.2012","article-title":"Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits","volume":"304","author":"Y Yamada","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"pone.0265347.ref015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ccep.2015.03.012","article-title":"Arrythmia in stem cell transplantation","volume":"7","author":"SO Almeida","year":"2015","journal-title":"Card Electrophysiol Clin"},{"key":"pone.0265347.ref016","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial first randomized placebo-controlled study of myoblast transplantation","volume":"117","author":"P Menasch\u00e9","year":"2008","journal-title":"Circulation"},{"key":"pone.0265347.ref017","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1253\/circj.CJ-20-0307","article-title":"Safety and efficacy of human Muse cell-based product for acute myocardial infarction in a first-in-human trial","volume":"84","author":"T Noda","year":"2020","journal-title":"Circ J"},{"key":"pone.0265347.ref018","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-4-431-56847-6_3","article-title":"Muse cells are endogenous reparative stem cells","volume":"1103","author":"Y Kushida","year":"2018","journal-title":"Adv Exp Med Biol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0265347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T21:41:23Z","timestamp":1648158083000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0265347"}},"subtitle":[],"editor":[{"given":"Meijing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0265347","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]}}}